Next Article in Journal
Long-Term Safety and Survival Outcomes of [225Ac]Ac-PSMA (Prostate-Specific Membrane Antigen) and [225Ac]Ac-/[177Lu]Lu-PSMA (TANDEM) Radioligand Therapy (PRLT) in Metastatic Castration-Resistant Prostate Cancer
Next Article in Special Issue
Systemic Treatment in Soft Tissue Sarcomas: Are We Making a Difference?
Previous Article in Journal
“Modernized” en Bloc Radical Cystectomy Versus Standard Radical Cystectomy: A Nationwide Multi-Institutional Propensity Score Matched Analysis
Previous Article in Special Issue
A Narrative Review of the Assessment and Treatment of Physical Impairments Commonly Seen in Sarcoma Cancer Survivors Using a Rehabilitative Approach
 
 
Review

Article Versions Notes

Cancers 2025, 17(3), 401; https://doi.org/10.3390/cancers17030401
Action Date Notes Link
article xml file uploaded 25 January 2025 12:05 CET Original file -
article xml uploaded. 25 January 2025 12:05 CET Update https://www.mdpi.com/2072-6694/17/3/401/xml
article pdf uploaded. 25 January 2025 12:05 CET Version of Record https://www.mdpi.com/2072-6694/17/3/401/pdf
article html file updated 25 January 2025 12:07 CET Original file https://www.mdpi.com/2072-6694/17/3/401/html
Back to TopTop